Pricing Options

/Pricing Options
Pricing Options 2018-03-29T20:17:07+00:00

Subscribe to the Leading GMP Regulatory Intelligence Newsletter

Trial

$$0
  • for 30 days
  • 1 Licensed User
  • -

Standard

$$1,995
  • Billed Annually
  • 1 Licensed User
  • -

Professional

$$5,995
  • Billed Annually
  • 5 Licensed Users
  • Special Reports**

Enterprise

$Price Varies
  • Call us at: 844-332-3320
  • Unlimited Users*
  • Special Reports**

*Enterprise Pricing Table

Number of Employees Price
Up to 500 $6,995
501 to 2,000 $10,995
2,001 to 10,000 $15,995
10,001 to 20,000 $19,995
20,000+ $24,995

**Special Reports

Includes special in-depth analyses and insights on newly published FDA data and trending issues.

Examples of special reports include:

  • FDA and MHRA Most Recent Drug Inspection Observations

  • Drug GMP Warning Letters by Year or Data Governance and Data Integrity

  • FDA Round-Up of Drug GMP Warning Letters by Year

Terms of Sale

  • A single license permits one user to log-in and use the site. Your IP is 54.82.7.231. If you purchased a Professional license, 5 users have access to the customer account. Enterprise licenses are available for unlimited users.
  • All fraud will be prosecuted.
  • This product is created and sold by Govzilla, Inc.
  • Copying the contents of any part of this site is considered a violation of our terms of service.
  • The vendor of this product reserves the right to do business or not do business with whom they choose.
  • All information submitted here is subject to our privacy policy.
  • Your information will be provided to the product's vendor upon successful completion of this sale.
  • By signing up for a Free Trial or purchasing any level of subscription, you are agreeing to these Terms of Sale, and the Govzilla, Inc. Terms.

FAQ

What is FDAzilla GMP Regulatory Intelligence Newsletter? 2018-03-27T01:37:35+00:00

WE WORK HARDER SO YOU WORK SMARTER

Is your team focused on staying ahead of the trends?

If you want to accomplish your organizational goals with less manpower, you need to leverage resources like GMP Regulatory Intelligence. As the pharma industry’s only weekly synthesis of all GMP regulatory and enforcement developments, this newsletter keeps your team up-to-date on relevant trends while saving your team countless hours trying to track down info. We find your needle in the haystack.

We've all been there before: going from site to site trying to track FDA laws, regulations, guidelines, and enforcement actions - it is a time-consuming and frustrating experience. The information is fragmented and sources can be unpredictable. Even worse, you have to filter out piles of unnecessary, unrelated information to find what you need.

If there was a way to get the key developments on a weekly basis, would that save you and your team a lot of time and headache? Of course. And there is a way.

What does the FDAzilla GMP Regulatory Intelligence Newsletter cover? 2018-03-27T01:39:33+00:00

EXACTLY THE RIGHT INFO EVERY WEEK

Every week, you'll get the quick run-down of FDA, EMA, PIC/S and ICH:

  • New laws
  • Regulations
  • Guidance
  • Concept papers published or posted that week

You'll get updates on:

  • FDA warning letters
  • FDA drug recalls
  • FDA import alerts for drugs and selected devices
  • Eudra GMDP reports of non-compliance
  • Regulatory actions that were published that week, including links to the source documents

You'll also be able to access links to the top stories in our industry. We read all of those stories each week and handpick the ones that are most relevant to you. Plus, we’ll periodically provide special in-depth analyses and insights on newly published FDA data and trending issues. You will also receive a monthly synthesis to reinforce key trends.

Who writes the FDAzilla GMP Regulatory Intelligence Newsletter? 2018-03-27T01:41:03+00:00

Meet industry veteran Barbara Unger. As the editor-in-chief of GMP Regulatory Intelligence and FDAzilla's GMP Quality Expert, she has been in your shoes.

Most recently, she was the Director of External Quality for Amgen. There, she designed, developed, implemented, and managed a sophisticated and comprehensive GMP Regulatory Intelligence program for 8 years. A key part of that program was surveillance of the environment on a daily basis and communication of time-sensitive and business-critical information to relevant management and staff in real time. Her newsletter inside Amgen was distributed broadly across the company - from VPs to front-line quality, operations, development, and regulatory personnel.

Barbara has also been an industry leader in the area of GMP Regulatory Intelligence. Barbara was a leader in Rx-360, the pharmaceutical and device global supply chain consortium founded in 2009. She was the founding chairperson for the Monitoring and Reporting team that identified and published summaries of GMP/GDP laws, regulations, and guidance that impacted the pharmaceutical and device industries. She led the group from its inception in 2009 through 2014. She was chairperson of the GMP Intelligence subgroup of the Midwest Discussion Group from 2010-2014.

Let Barbara do the scanning, filtering, analysis, and synthesis for you.

Who benefits from reading the FDAzilla GMP Regulatory Intelligence Newsletter? 2018-03-27T01:43:03+00:00

Anyone who is involved in and impacted by drug and biologic product quality developments, including regulators, manufacturers, contractors, suppliers, consultants, lawyers, academics and their associations and related standard-setting organizations.

How is the FDAzilla GMP Regulatory Intelligence Newsletter delivered? 2018-03-27T01:45:11+00:00

The weekly, monthly, and special publications and the archives are available to subscribers electronically via web site access. When new content is published on the web site, subscribers will receive an email notifying them.

How do I get a subscription or a site license? 2018-03-28T17:59:56+00:00

The FDAzilla GMP Regulatory Intelligence Newsletter is available either through individual subscriptions or site/organization-wide licenses described above. If you want to purchase a single license or the Professional license that includes up to 5 users, you can purchase those subscriptions by clicking the appropriate "Sign Up Now!" button above. If you want to purchase an Enterprise Subscription, you can either call us directly (844-332-3320) or schedule a call at your convenience by clicking the "Schedule a Call" button.

Why should I subscribe to the FDAzilla GMP Regulatory Intelligence Newsletter? 2018-03-28T18:01:37+00:00

Is your team focused on staying ahead of the trends?

If you want to accomplish your organizational goals with less manpower, you need to leverage resources like GMP Regulatory Intelligence. As the pharma industry’s only weekly synthesis of all GMP regulatory and enforcement developments, this newsletter keeps your team up-to-date on relevant trends while saving your team countless hours trying to track down info. We find your needle in the haystack.

We've all been there before: going from site to site trying to track FDA laws, regulations, guidelines, and enforcement actions - it is a time-consuming and frustrating experience. The information is fragmented and sources can be unpredictable. Even worse, you have to filter out piles of unnecessary, unrelated information to find what you need.

If there was a way to get the key developments on a weekly basis, would that save you and your team a lot of time and headache? Of course. And there is a way. Subscribe today.

error: Copying any content on this site is a violation of Copyright laws.